Urolithiasis pp 627-630 | Cite as

Combined Primary Hyperparathyroidism and Absorptive Hypercalciuria: Clinical Implications

  • N. A. Breslau
  • C. Y. C. Pak


Primary hyperparathyroidism accounts for five % of kidney stones. This is our experience as well as that of others. Absorptive hypercalciuria, characterized by excessive intestinal absorption of calcium, is present in 45% of stone formers. It should not be surprising that these two common causes of nephrolithiasis may occasionally occur together. In this report, we describe five patients who presented with combined primary hyperparathyroidism and absorptive hypercalciuria. It will be shown that when these disorders occur together, there are important implications both before and after parathyroidectomy.


Kidney Stone Primary Hyperparathyroidism Parathyroid Adenoma Intestinal Calcium Absorption Mild Hypercalcemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pak CYC, Kaplan RA, Bone H, Townsend J, and Waters O, 1975, A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias, NEJM, 292: 497.PubMedCrossRefGoogle Scholar
  2. 2.
    Broadus AE, Horst RL, Lang R, Littledike ET, and Rasmussen H, 1980, The importance of circulating 1, 25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism, NEJM, 302: 421.PubMedCrossRefGoogle Scholar
  3. 3.
    Insogna KL, Broadus AE, Dreyer BE, Ellison AF, and Gertner JM, 1985, Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria, J Clin Endocrinol & Metab, 61: 490.CrossRefGoogle Scholar
  4. 4.
    Slatopolsky E, Weerts C., Thielan J, Horst R, Harter H, and Martin KJ, 1984, Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferoi in uremic patients, J Clin Invest, 74: 2136.PubMedCrossRefGoogle Scholar
  5. 5.
    Insogna KL, Mitnick ME, Stewart AF, Burtis WJ, Mallette LE, and Broadus AE, 1985, Sensitivity of the parathyroid hormone-1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism, NEJM, 313: 1126.PubMedCrossRefGoogle Scholar
  6. 6.
    Broadus AE, 1982, Primary hyperparathyroidism viewed as a bihormonal disease process, Mineral Electrolyte Metab, 8: 199.Google Scholar
  7. 7.
    Patron P, Gardin JP, and Paillard M, 1987, Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism, Kidney Internat, 31: 1174.CrossRefGoogle Scholar
  8. 8.
    Siminovitch JMP, Esselstyn CB Jr, and Straffon RA, 1981, Renal lithiasis and hyperparathyroidism: diagnosis, management and prognosis, J Urol, 126: 720.PubMedGoogle Scholar
  9. 9.
    Parks J, Coe F, and Favus M, 1980, Hyperparathyroidism in nephrolithiasis, Arch Intern Med, 140: 1479.PubMedCrossRefGoogle Scholar
  10. 10.
    Bone HG III, Zerwekh JE, Haussler MR, and Pak CYC, 1979, Effect of parathyroidectomy on serum 1κ, 25-dihydroxyvitamin D and intestinal calcium absorption in primary hyperparathyroidism, J Clin Endocrinol & Metab, 48: 877.CrossRefGoogle Scholar
  11. 11.
    Muir JW, and Baker LRI, 1978, Hypercalciuria and recurrent urinary stone formation despite successful surgery for primary hyperparathyroidism, Brit Med J, 2: 738.PubMedCrossRefGoogle Scholar
  12. 12.
    Maschio G, Vecchioni R, and Tessitore N, 1980, Recurrence of autonomous hyperparathyroidism in calcium nephrolithiasis, Am J Med, 69: 607.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • N. A. Breslau
    • 1
  • C. Y. C. Pak
    • 1
  1. 1.Center for Mineral Metabolism and Clinical Research, Department of Internal MedicineUniversity of Texas Southwestern Medical Center at DallasDallasUSA

Personalised recommendations